AACR Princess Takamatsu Memorial Lectureship

Dr. Loeb will deliver his Award Lecture entitled Human Cancers Exhibit a Mutator Phenotype: Origin and Consequences, at the 2008 AACR Annual Meeting in San Diego, CA. The Award ceremony and lecture will be held Tuesday, April 15, 2008 from 1:15 p.m. - 2:15 p.m.  For 2008 Annual Meeting information, please click here.

The Lectureship

The AACR Princess Takamatsu Memorial Lectureship was established and first presented in 2007 in honor of the late Princess Takamatsu of Japan. During her extraordinary life, Her Imperial Highness Princess Takamatsu expended tremendous efforts toward the public and humanitarian cause of the eradication of cancer. She is regarded as an honored and respected figure in Japan, the United States, and within the international cancer research community as a whole.  

To learn more about Princess Takamatsu, click here.

This Lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the Princess to multinational collaborations. The recipient of the 2nd Annual Lectureship will present a major, 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009).

The Lecturer will receive an unrestricted cash award of US$10,000, support to attend the AACR Annual Meeting, and a commemorative item serving as tangible witness to the singular honor of his/her selection.

Eligibility Criteria

• Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
  
• The Lectureship will be presented to an individual investigator.
  
• Institutions or organizations are not eligible for the Lectureship.
  
  

Nomination Process

Nominations for the 2009 Lectureship Will Open Spring 2008.

Nominations for the Lectureship must be submitted electronically to monique.eversley@aacr.org no later than 4:00 p.m. US Eastern Time on October 15, 2008. Paper nominations will not be accepted.

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.

Candidates may not nominate themselves.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates nominated by any institution or nominator.

Nomination Materials

The following materials must be sent electronically to the AACR as noted above. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

1) Letter of Recommendation. The letter of recommendation must:

• be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
  
• specify the AACR Lectureship for which the candidate is being nominated; and
  
• describe the candidate's novel and significant work in cancer research and dedication to multinational collaborations, with the publications supporting these accomplishments directly referenced within the letter.

2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.

3) Summary Statement. A statement of no more than 50 words summarizing the candidate's accomplishments for which he or she is being nominated.

Selection

Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. Selection of the Lecturer will be made on the basis of the novel and significant work, its far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and his or her embodiment of the dedication of the Princess to multinational collaborations. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision.

Supporter

Generously supported by Princess Takamatsu Cancer Research Foundation (Japan).

Questions?

Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404